Human Drugs View

Product Information
Registration Number BR-1462
Generic Name Ocrelizumab
Brand Name Ocrevus
Dosage Strength 300 mg/10 ml (30 mg/ml)
Dosage Form Concentrate for Solution for Intravenous Infusion.
Classification Prescription Drug (RX)
Pharmacologic Category Selective Immunosuppresant
Packaging 15 mL colorless USP/Ph. Eur./JP Type I glass vial with a 20 mm rubber stopper laminated with fluororesin film, which is crimped with a 20 mm aluminum seal fitted with a plastic flip-off cap
Manufacturer Roche Diagnostics GmbH
Country of Origin Germany
Trader
Importer Roche (Philippines), Inc.
Distributor
Application Type Monitored Release
Issuance Date 22 December 2023
Expiry Date 22 December 2028